Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
European Urology|September 20, 2011
Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01)Stéphane Culine, Aude Fléchon, Aline Guillot, et al.
Oncology|July 23, 2011
5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinomaElias Assaf, Muriel Verlinde-Carvalho, Catherine Delbaldo, et al.
European Urology|June 27, 2021
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic ReviewRicardo Leão, Maarten Albersen, Leendert H J Looijenga, et al.
Frontiers in Oncology|August 15, 2022
Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic StudiesLeonard Lugand, Guillaume Mestrallet, Rebecca Laboureur, et al.
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Cancer Immunology Research|August 28, 2019
CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-GClement Dumont, Alix Jacquier, Jerome Verine, et al.
Future Oncology (London, England)|February 20, 2025
Epidemiology, resource use, and treatment patterns of locally advanced or metastatic urothelial carcinoma in FranceFlorence Joly, Stephane Culine, Morgan Roupret, et al.
Clinical Genitourinary Cancer|August 25, 2016
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary CohortDamien Pouessel, Sylvie Bastuji-Garin, Nadine Houédé, et al.
The Oncologist|February 1, 2021
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA CohortVincent Esteyrie, Caroline Dehais, Elodie Martin, et al.
The Oncologist|March 16, 2026
Identification of new prognostic molecular markers in glioblastoma: a single-center retrospective studyAdèle Meola, Bertille Segier, Aurore Siegfried, et al.
Pageof 12